Literature DB >> 8886634

Endoscopic ultrasonographic diagnosis of pancreatic cancer complicating chronic pancreatitis.

M Barthet1, I Portal, J Boujaoude, J P Bernard, J Sahel.   

Abstract

BACKGROUND AND STUDY AIMS: Pancreatic cancer is a rare complication of chronic pancreatitis (CP), and its diagnosis remains difficult. The present study attempted to evaluate the ability of endoscopic ultrasonography (EUS) to diagnose pancreatic masses associated with CP and provide evidence of malignancy in patients with a pancreatic mass on EUS. PATIENTS AND METHODS: Between 1991 and 1994, EUS examinations yielded a diagnosis of CP in 85 patients at our institution. Forty patients had early CP, 18 had pancreatic pseudocysts complicating CP, and 27 had advanced chronic pancreatitis - five of whom were considered as presenting pancreatic cancer associated with CP.
RESULTS: The five patients studied had jaundice, weight loss, and calcifications visible on plain abdominal films. Three of them had histological confirmation of pancreatic carcinoma. The pancreatic carcinomas were hypoechoic masses of 20-35 mm, with an irregular, rounded shape. Calcifications were limited to the periphery of the hypoechoic masses. Two patients had negative EUS-guided cytological punctures, and are still alive two years later. They were considered as false-positive cases. EUS showed a hypoechoic mass with peripheral calcifications in one of these false-positive patients, with a large central calcification in the other case. The overall sensitivity of EUS for the diagnosis of pancreatic carcinoma was 100%, but the positive predictive value was 60%.
CONCLUSION: EUS is highly sensitive in detecting abnormal masses in cases of CP, but the positive predictive value of the diagnosis of pancreatic cancer seems to be weak.

Entities:  

Mesh:

Year:  1996        PMID: 8886634     DOI: 10.1055/s-2007-1005528

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  Follow-up of patients with pseudotumoral chronic pancreatitis: outcome and surveillance.

Authors:  Félix Ignacio Téllez-Ávila; Alvaro Villalobos-Garita; Marc Giovannini; Carlos Chan; Jorge Hernández-Calleros; Luis Uscanga; Miguel Ángel Ramírez-Luna
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Endoscopic ultrasound in chronic pancreatitis: where are we now?

Authors:  Andrada Seicean
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 3.  Role of endoscopic ultrasound in the diagnosis of pancreatic cancer.

Authors:  Juana Gonzalo-Marin; Juan Jose Vila; Manuel Perez-Miranda
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

4.  Pseudotumorous chronic pancreatitis associated with inflammatory bowel disease.

Authors:  P Grandval; M Barthet; A Desjeux; S Garcia; C Boustiere; B Poilroux; J C Grimaud
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

5.  Endoscopic ultrasonography for pancreatic cancer: current and future perspectives.

Authors:  Claudio De Angelis; Rosario Francesco Brizzi; Rinaldo Pellicano
Journal:  J Gastrointest Oncol       Date:  2013-06

6.  Incidence and characteristics of chronic and lymphoplasmacytic sclerosing pancreatitis in patients scheduled to undergo a pancreatoduodenectomy.

Authors:  Steve M M de Castro; Lindsey C F de Nes; C Yung Nio; Daan C Velseboer; Fiebo J W ten Kate; Olivier R C Busch; Thomas M van Gulik; Dirk Jan Gouma
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

Review 7.  Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma.

Authors:  Xu Hua Gong; Jian Rong Xu; Li Jun Qian
Journal:  Abdom Radiol (NY)       Date:  2021-04-29

8.  Discriminating chronic pancreatitis from pancreatic cancer: Contrast-enhanced EUS and multidetector computed tomography in direct comparison.

Authors:  Finn-J Rn Harmsen; Dirk Domagk; Christoph F Dietrich; Michael Hocke
Journal:  Endosc Ultrasound       Date:  2018 Nov-Dec       Impact factor: 5.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.